Grant: Canada Research Chairs
University of Toronto
$120,000.00
Single Virus Particle Analyses
FY 2024-25
Summary
The recent SARS-CoV-2 pandemic and persistence of the HIV pandemic have demonstrated the need to better characterize virus particles and their associated surface proteins. Importantly, viral surface proteins can significantly influence virus infection by altering where viruses transit in the human body and how they interact with immune cells. Therefore, advancing the methods to study these proteins and strategize optimal viral therapeutics/vaccines is critical. Dr. Guzzo’s research has pioneered a series of ground-breaking methods for analyzing human proteins on virus particles with a novel technique called flow virometry (FV). FV is an emerging technique that uses antibodies and standardized reference materials to quantify proteins on the surface of individual virus particles, using similar experimental principles to flow cytometry, which is more traditionally used to analyze individual cells and their associated proteins. Importantly, few researchers and labs worldwide have the expertise and cutting-edge instrumentation required to perform FV on HIV particles, mainly because these virus particles are ~100X smaller than cells, and therefore resolving nanoscale particles and their low levels of particle-associated fluorescence is typically below the limit of detection for commonly used cytometers.
As a Tier 2 Canada Research Chair in Single Virus Particle Analyses, Dr. Guzzo will pioneer additional novel approaches to study single virus particles, leading to enhanced discovery and innovation across broad fields of study related to nanoparticles. This CRC has three aims: 1) advancing flow virometry methods for enhanced sensitivity of detecting viral surface proteins; 2) pioneering new methods to purify homogenous virus populations for downstream biological studies; and 3) applying flow virometry to advance bioengineering of therapeutic nanoparticles and diagnostics. These novel approaches will generate significant advances in knowledge of virus biology, including identifying new proteins that can influence virus trafficking, binding, and infection of human cells. Dr. Guzzo’s innovative research techniques and approaches to studying viruses at a single particle resolution have established her as a world leader in this field and the support of this CRC will accelerate her ability to yield new discoveries in virus biology and innovation in nanoparticle technologies.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CRC-2023-00257
Name nom
Guzzo, Christina
Department département
Biological Sciences - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1060606
Field of research list names en
Transcriptomics
Field of research list names fr
Transcriptomique
Socioeconomic objective list codes
RDS10704
Socioeconomic objective list names en
Specific population health
Socioeconomic objective list names fr
Santé de populations précises
Application title
Single Virus Particle Analyses
Keywords
Human immunodeficiency virus (HIV); Virion-incorporated proteins; Virus sorting; Viral proteomics; Viral diagnostics; Nanoparticles; Nanoscale cytometry
Application summary
The recent SARS-CoV-2 pandemic and persistence of the HIV pandemic have demonstrated the need to better characterize virus particles and their associated surface proteins. Importantly, viral surface proteins can significantly influence virus infection by altering where viruses transit in the human body and how they interact with immune cells. Therefore, advancing the methods to study these proteins and strategize optimal viral therapeutics/vaccines is critical. Dr. Guzzo’s research has pioneered a series of ground-breaking methods for analyzing human proteins on virus particles with a novel technique called flow virometry (FV). FV is an emerging technique that uses antibodies and standardized reference materials to quantify proteins on the surface of individual virus particles, using similar experimental principles to flow cytometry, which is more traditionally used to analyze individual cells and their associated proteins. Importantly, few researchers and labs worldwide have the expertise and cutting-edge instrumentation required to perform FV on HIV particles, mainly because these virus particles are ~100X smaller than cells, and therefore resolving nanoscale particles and their low levels of particle-associated fluorescence is typically below the limit of detection for commonly used cytometers.
As a Tier 2 Canada Research Chair in Single Virus Particle Analyses, Dr. Guzzo will pioneer additional novel approaches to study single virus particles, leading to enhanced discovery and innovation across broad fields of study related to nanoparticles. This CRC has three aims: 1) advancing flow virometry methods for enhanced sensitivity of detecting viral surface proteins; 2) pioneering new methods to purify homogenous virus populations for downstream biological studies; and 3) applying flow virometry to advance bioengineering of therapeutic nanoparticles and diagnostics. These novel approaches will generate significant advances in knowledge of virus biology, including identifying new proteins that can influence virus trafficking, binding, and infection of human cells. Dr. Guzzo’s innovative research techniques and approaches to studying viruses at a single particle resolution have established her as a world leader in this field and the support of this CRC will accelerate her ability to yield new discoveries in virus biology and innovation in nanoparticle technologies.